Abbott achangopedza kuunza miriyoni zana nemakumi mashanu ekukurumidza bvunzo dzeantigen kuhurumende yemubatanidzwa kuti iparadzirwe zvakanyanya mukupindura denda reCCIDID-150, vaongorori kubva kuCenters for Disease Control and Prevention (CDC) vakaburitsa ongororo yaiti kuongororwa kwakavakirwa pamakadhi kunogona. kusatapuriranwa Zvinenge zvikamu zviviri muzvitatu zvezvisina zviratidzo.
Chidzidzo ichi chakaitwa nevakuru vehutano munharaunda yePima County, Arizona, yakakomberedza Tucson City.Chidzidzo ichi chakaunganidza mapepa maviri kubva kune vanopfuura 3,400 vakuru nevachiri kuyaruka.Imwe swab yakaedzwa uchishandisa Abbott's BinaxNOW bvunzo, nepo imwe yacho yakagadziriswa uchishandisa PCR-based molecular test.
Pakati peavo vakaedza kuti vane hutachiwana, vaongorori vakawana kuti bvunzo yeantigen yakanyatsoona hutachiona hweCCIDID-19 mu35.8% yeavo vasina kutaura chero zviratidzo, uye 64.2% yeavo vakati vainzwa kusanzwa zvakanaka mumavhiki maviri ekutanga.
Nekudaro, marudzi akasiyana ebvunzo dzekoronavirus haagone kugadzirwa zvakafanana munzvimbo dzakasiyana siyana uye mamiriro, uye anogona kusiyana zvichienderana nezvinhu zvakaongororwa uye nguva yekushandiswa.Sezvakataurwa naAbbott (Abbott) mukutaura, bvunzo dzayo dzakaita zvirinani pakutsvaga vanhu vane hutachiona uye hwehutachiona hwehutachiona (kana masampuli ane hutachiona hunorimika).
Iyo kambani yakataura kuti "BinaxNOW yakanaka kwazvo pakuona vanhu vane hutachiona," inonongedza kune vane hunyanzvi.Muedzo wakaratidza 78.6% yevanhu vanogona kurima hutachiona asi asymptomatic uye 92.6% yevanhu vane zviratidzo.
Iyo immunoassay bvunzo izere mubepa kabhuku saizi yekadhi rechikwereti ine donje swab yakaiswa uye yakasanganiswa nemadonhwe mubhodhoro reagent.Mutsara wemitsetse inemavara waitaridza kupa mhinduro yakanaka, yakaipa kana kuti isiriyo.
Chidzidzo cheCDC chakawana kuti bvunzo yeBinaxNOW zvakare yakanyanya.Pakati pevatori vechikamu vane zviratidzo vakashuma zviratidzo zvechirwere mumazuva manomwe apfuura, kunzwisiswa kwaive 71.1%, inova imwe yemvumo yekushandisa bvunzo yakabvumidzwa neFDA.Panguva imwecheteyo, data yekiriniki yaAbbott yakaratidza kuti kunzwa kweboka rimwe chete revarwere kwaive 84.6%.
Iyo kambani yakati: "Zvakakosha, idzi data dzinoratidza kuti kana murwere asina zviratidzo uye mhedzisiro yacho yakaipa, BinaxNOW ichapa mhinduro chaiyo 96.9% yenguva," kambani inoreva kuyerwa chaiko kwebvunzo.
The US Centers for Disease Control and Prevention (CDC) yakabvumirana neongororo iyi, ichiti kukurumidza kuyedza antigen kune yakaderera-yechokwadi mhedzisiro chiyero (kunyangwe paine zvisingakwanisi kana zvichienzaniswa nerabhoritari-run PCR bvunzo) nekuda kwekureruka kwekushandisa uye nekukurumidza. kugadzirisa Nguva uye mutengo wakaderera zvichiri chinhu chakakosha chekuongorora.Kugadzira uye kushanda.
Vatsvagiri vacho vakati: "Vanhu vanoziva mhedzisiro yebvunzo mukati memaminitsi gumi nemashanu kusvika makumi matatu vanogona kugariswa vega nekukurumidza uye vanogona kutanga kutarisisa kuonana nekumberi uye vanoshanda zvakanyanya pane kudzosa bvunzo mazuva mashoma gare gare.""Antigen test inoshanda zvakanyanya."Nguva yekukurumidza kutendeuka inogona kubatsira kudzikisira kupararira nekuzivisa vanhu vane hutachiona kuti vagadzirwe nekukurumidza, kunyanya kana vakashandiswa sechikamu chechirongwa chekuyedza. "
Abbott akataura mwedzi wapera kuti inoronga kutanga kupa BinaxNOW bvunzo zvakananga zvekutengesa zvekutengesa kuti zvishandiswe kumba uye pa-saiti nevarapi vehutano, uye inoronga kuendesa imwe 30 miriyoni BinaxNOW bvunzo pakupera kwaKurume, uye imwe 90 miriyoni kupera kwaJune.
Nguva yekutumira: Feb-25-2021